Background: Ovarian cancer is one of the most lethal gynecological cancers, with an age-standardized incidence rate of 3.0–11.4 per 100,000 women worldwide [1], and is commonly diagnosed at an advanced stage with poor survival outcomes. Accurate staging is essential for treatment planning, and CT is the recommended imaging modality for assessing the extent of ovarian malignancy and tumour resectability. The purpose of this study was to correlate pre-operative CT scan findings with surgicopathological staging in patients with ovarian cancer. Methods: This observational, cross-sectional study was conducted at the Department of Gynecological Oncology, National Institute of Cancer Research & Hospital (NICRH), Dhaka, Bangladesh, from January to December 2021. A total of 100 women with suspected ovarian cancer underwent pre-operative CT and surgery, with CT, per-operative, and histopathological findings compared according to the 2014 FIGO staging system. Data were analysed using SPSS version 23.0; p<0.05 was considered significant. Results: Among 100 patients, mean age was 43.2 ± 11.7 years; most were aged 41–50 years (38, 38.0%), urban (66, 66.0%), and poor socioeconomic status (44, 44.0%). All had a lower abdominal lump (100, 100.0%), and anemia was present in 72 (72.0%). Most masses were unilateral (72, 72.0%) and solid (78, 78.0%). Stage IA predominated on CT (60, 60.0%), peroperative (42, 42.0%), and histopathological (41, 41.0%) staging. Papillary serous cystadenocarcinoma was most common (64, 64.0%). CT sensitivity was 100.0% for IA, IIIB, and IIIC. Conclusion: Pre-operative CT scan is a useful tool for staging ovarian cancer, although early-stage disease may be under-staged compared with surgicopathological assessment.